BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 26427796)

  • 1. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration.
    Yokoyama U; Minamisawa S; Quan H; Akaike T; Jin M; Otsu K; Ulucan C; Wang X; Baljinnyam E; Takaoka M; Sata M; Ishikawa Y
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1547-55. PubMed ID: 18689492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
    Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.
    Kohno T; Urao N; Ashino T; Sudhahar V; McKinney RD; Hamakubo T; Iwanari H; Ushio-Fukai M; Fukai T
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):805-13. PubMed ID: 23349186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.
    Ostriker A; Horita HN; Poczobutt J; Weiser-Evans MC; Nemenoff RA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):877-86. PubMed ID: 24526697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
    Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
    Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
    Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
    Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
    Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
    Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
    Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
    J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
    Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin Induces Sca-1
    Xie Y; Potter CMF; Le Bras A; Nowak WN; Gu W; Bhaloo SI; Zhang Z; Hu Y; Zhang L; Xu Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2114-2127. PubMed ID: 28935755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation.
    Dutzmann J; Koch A; Weisheit S; Sonnenschein K; Korte L; Haertlé M; Thum T; Bauersachs J; Sedding DG; Daniel JM
    Cardiovasc Res; 2017 Nov; 113(13):1653-1663. PubMed ID: 29088375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.